drugset / Trial / NCT00784862

ATAC - Pharmacokinetics (PK) Sub-Protocol

NCT00784862

Phase 3 Completed 9358 enrolled AstraZeneca
RandomizedParallel-groupDouble-blindTreatment

Summary

To assess the effect of ARIMIDEX on the pharmacokinetics of tamoxifen and the effects of tamoxifen on the pharmacokinetics of ARIMIDEX..

Timeline

Start
1998-06
Primary completion
Completion
1999-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Anastrozole Other / unclassified 1 mg Oral
Comparator Tamoxifen Small molecule 20 mg Oral

Indications